• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LIU Jiamin, JIA Xiaoqing, DI Bin. Application of three-dimensional cell model in tumor research[J]. Journal of China Pharmaceutical University, 2020, 51(2): 152-160. DOI: 10.11665/j.issn.1000-5048.20200204
Citation: LIU Jiamin, JIA Xiaoqing, DI Bin. Application of three-dimensional cell model in tumor research[J]. Journal of China Pharmaceutical University, 2020, 51(2): 152-160. DOI: 10.11665/j.issn.1000-5048.20200204
shu

Application of three-dimensional cell model in tumor research

More Information
    Graphical Abstract
    • Abstract
  • The three-dimensional cell model cultures different types of cells in vitro. By means of special materials or carriers, the cells can grow, migrate and differentiate in a three-dimensional environment. The three-dimensional cell model provides the cells with an in vitro environment that is close to in vivo, making the gene expression and signal exchange of the cells more physiologically relevant. This paper starts with the concept and classification of three-dimensional cell model, then summarizes the applications and progresses of three-dimensional cell model in tumor micro-environment, cancer metastasis and anti-tumor drug development in recent years. Based on the current shortcomings of the three-dimensional cell model, this paper presents the assumptions and prospects for the application of three-dimensional cell model in tumor therapy.
    • FullText(HTML)
    • References (59)
  • [1]
    Amelian A,Wasilewska K,Megias D,et al.Application of standard cell cultures and 3D in vitro tissue models as an effective tool in drug design and development[J].Pharmacol Rep,2017,69(5):861-870.
    [2]
    Lovitt CJ,Shelper TB,Avery VM.Cancer drug discovery:recent innovative approaches to tumor modeling[J].Expert Opin Drug Discov,2016,11(9):885-894.
    [3]
    Hutchinson L, Kirk R. High drug attrition rates: where are we going wrong[J]?Nat Rev Clin Oncol,2011,8(4):189-190.
    [4]
    Lelièvre SA,Kwok T,Chittiboyina S.Architecture in 3D cell culture:an essential feature for in vitro toxicology[J].Toxicol In Vitro,2017,45(Pt 3):287-295.
    [5]
    Weiswald LB,Bellet D,Dangles-Marie V.Spherical cancer models in tumor biology[J].Neoplasia,2015,17(1):1-15.
    [6]
    Kapaczyńska M,Kolenda T,Przybya W,et al.2D and 3D cell cultures—a comparison of different types of cancer cell cultures[J].Arch Med Sci,2018,14(4):910-919.
    [7]
    Knight E,Przyborski S.Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro[J].J Anat,2015,227(6):746-756.
    [8]
    Souza AG,Silva IBB,Campos-Fernandez E,et al.Comparative assay of 2D and 3D cell culture models:proliferation,gene expression and anticancer drug response[J].Curr Pharm Des,2018,24(15):1689-1694.
    [9]
    Antoni D,Burckel H,Josset E,et al.Three-dimensional cell culture:a breakthrough in vivo[J].Int J Mol Sci,2015,16(3):5517-5527.
    [10]
    Li ZW, Araoka T, Wu J, et al. 3D culture supports long-term expansion of mouse and human nephrogenic progenitors[J].Cell Stem Cell,2016,19(4):516-529.
    [11]
    Ham SL,Joshi R,Thakuri PS,et al.Liquid-based three-dimensional tumor models for cancer research and drug discovery[J].Exp Biol Med(Maywood),2016,241(9):939-954.
    [12]
    Rijal G,Li WM.3D scaffolds in breast cancer research[J].Biomaterials,2016,81:135-156.
    [13]
    Rijal G,Bathula C,Li WM.Application of synthetic polymeric scaffolds in breast cancer 3D tissue cultures and animal tumor models[J].Int J Biomater,2017,2017:8074890.
    [14]
    Veelken C,Bakker GJ,Drell D,et al.Single cell-based automated quantification of therapy responses of invasive cancer spheroids in organotypic 3D culture[J].Methods,2017,128:139-149.
    [15]
    Li YZ,Rogoff HA,Keates S,et al.Suppression of cancer relapse and metastasis by inhibiting cancer stemness[J].Proc Natl Acad Sci U S A,2015,112(6):1839-1844.
    [16]
    Ishiguro T,Ohata H,Sato A,et al.Tumor-derived spheroids:relevance to cancer stem cells and clinical applications[J].Cancer Sci,2017,108(3):283-289.
    [17]
    Ham SL,Joshi R,Thakuri PS,et al.Liquid-based three-dimensional tumor models for cancer research and drug discovery[J].Exp Biol Med(Maywood),2016,241(9):939-954.
    [18]
    Thoma CR,Zimmermann M,Agarkova I,et al.3D cell culture systems modeling tumor growth determinants in cancer target discovery[J].Adv Drug Deliv Rev,2014,69/70:29-41.
    [19]
    Mehta G,Hsiao AY,Ingram M,et al.Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy[J].J Control Release,2012,164(2):192-204.
    [20]
    Estrada MF,Rebelo SP,Davies EJ,et al.Modelling the tumour microenvironment in long-term microencapsulated 3D co-cultures recapitulates phenotypic features of disease progression[J].Biomaterials,2016,78:50-61.
    [21]
    Kaukonen R,Jacquemet G,Hamidi H,et al.Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment[J].Nat Protoc,2017,12(11):2376-2390.
    [22]
    Lazzari G,Nicolas V,Matsusaki M,et al.Multicellular spheroid based on a triple co-culture:a novel 3D model to mimic pancreatic tumor complexity[J].Acta Biomater,2018,78:296-307.
    [23]
    Burgstaller G,Sengupta A,Vierkotten S,et al.Distinct niches within the extracellular matrix dictate fibroblast function in(cell free)3D lung tissue cultures[J].Am J Physiol Lung Cell Mol Physiol,2018,314(5):L708-L723.
    [24]
    Chevrier S,Levine JH,Zanotelli VRT,et al.An immune atlas of clear cell renal cell carcinoma[J].Cell,2017,169(4):736-749.e18.
    [25]
    Munn DH,Bronte V.Immune suppressive mechanisms in the tumor microenvironment[J].Curr Opin Immunol,2016,39:1-6.
    [26]
    Osswald A,Hedrich V,Sommergruber W.3D-3 tumor models in drug discovery for analysis of immune cell infiltration[J].Methods Mol Biol,2019,1953:151-162.
    [27]
    Balachander GM,Balaji SA,Rangarajan A,et al.Enhanced metastatic potential in a 3D tissue scaffold toward a comprehensive in vitro model for breast cancer metastasis[J].ACS Appl Mater Interfaces,2015,7(50):27810-27822.
    [28]
    Malandrino A,Kamm RD,Moeendarbary E.In vitro modeling of mechanics in cancer metastasis[J].ACS Biomater Sci Eng,2018,4(2):294-301.
    [29]
    Chitty JL,Filipe EC,Lucas MC,et al.Recent advances in understanding the complexities of metastasis[J].F1000Res,2018,7:1169.doi: 10.12688/f1000research.15064.2.
    [30]
    Balachander GM,Balaji SA,Rangarajan A,et al.Enhanced metastatic potential in a 3D tissue scaffold toward a comprehensive in vitro model for breast cancer metastasis[J].ACS Appl Mater Interfaces,2015,7(50):27810-27822.
    [31]
    Janani G,Pillai MM,Selvakumar R,et al.An in vitro 3D model using collagen coated gelatin nanofibers for studying breast cancer metastasis[J].Biofabrication,2017,9(1):015016.
    [32]
    Toh YC,Raja A,Yu H,et al.A 3D microfluidic model to recapitulate cancer cell migration and invasion[J].Bioengineering(Basel),2018,5(2):E29.
    [33]
    Romero-López M,Trinh AL,Sobrino A,et al.Recapitulating the human tumor microenvironment:colon tumor-derived extracellular matrix promotes angiogenesis and tumor cell growth[J].Biomaterials,2017,116:118-129.
    [34]
    Velez DO,Tsui B,Goshia T,et al.3D collagen architecture induces a conserved migratory and transcriptional response linked to vasculogenic mimicry[J].Nat Commun,2017,8(1):1651.
    [35]
    Leight JL,Tokuda EY,Jones CE,et al.Multifunctional bioscaffolds for 3D culture of melanoma cells reveal increased MMP activity and migration with BRAF kinase inhibition[J].Proc Natl Acad Sci U S A,2015,112(17):5366-5371.
    [36]
    Fang Y,Eglen RM.Three-dimensional cell cultures in drug discovery and development[J].SLAS Discov,2017,22(5):456-472.
    [37]
    Verjans ET,Doijen J,Luyten W,et al.Three-dimensional cell culture models for anticancer drug screening:worth the effort[J]?J Cell Physiol,2018,233(4):2993-3003.
    [38]
    Mosaad E,Chambers K,Futrega K,et al.Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures[J].BMC Cancer,2018,18(1):592.
    [39]
    Rijal G,Li WM.A versatile 3D tissue matrix scaffold system for tumor modeling and drug screening[J].Sci Adv,2017,3(9):e1700764.doi: 10.1126/sciadv.1700764.
    [40]
    Yan XJ,Zhou L,Wu ZZ,et al.High throughput scaffold-based 3D micro-tumor array for efficient drug screening and chemosensitivity testing[J].Biomaterials,2019,198:167-179.
    [41]
    Lu MX,Henry CE,Lai HW,et al.A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles[J].Biomater Sci,2019,7(4):1652-1660.
    [42]
    Ma JY,Li N,Wang YC,et al.Engineered 3D tumour model for study of glioblastoma aggressiveness and drug evaluation on a detachably assembled microfluidic device[J].Biomed Microdevices,2018,20(3):80.
    [43]
    Liu QX,Zhang ZJ,Liu YP,et al.Cancer cells growing on perfused 3D collagen model produced higher reactive oxygen species level and were more resistant to cisplatin compared to the 2D model[J].J Appl Biomater Funct Mater,2018,16(3):144-150.
    [44]
    Imamura Y,Mukohara T,Shimono Y,et al.Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer[J].Oncol Rep,2015,33(4):1837-1843.
    [45]
    Li JQ,Wu X,Gan L,et al.Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells[J].Acta Pharmacol Sin,2017,38(12):1642-1654.
    [46]
    Guo LL,Xu YR,Zhang L,et al.Advances in the application of three-dimensional tumor spheroids model in the mechanism study of drug resistance[J].J China Pharm Univ(中国药科大学学报),2018,49(5):521-527.
    [47]
    Huang YY,Wang SQ,Kessel S,et al.Characterizing 3D morphology of multicellular tumor spheroids using optical coherence tomography(Conference Presentation)[C].SPIE BiOS,Optical Coherence Tomography and Coherence Domain Optical Methods in Biomedicine XXI,100530T(2017-04-19);https://doi.org/10.1117/12.2254920.
    [48]
    Vinci M,Gowan S,Boxall F,et al.Advances in establishment and analysis of three-dimensional tumor spheroid-based functional assays for target validation and drug evaluation[J].BMC Biol,2012,10:29.
    [49]
    Ivascu A,Kubbies M.Diversity of cell-mediated adhesions in breast cancer spheroids[J].Int J Oncol,2007,31(6):1403-1413.
    [50]
    Schwartz AD,Barney LE,Jansen LE,et al.A biomaterial screening approach reveals microenvironmental mechanisms of drug resistance[J].Integr Biol(Camb),2017,9(12):912-924.
    [51]
    Breslin S,O′Driscoll L.The relevance of using 3D cell cultures,in addition to 2D monolayer cultures,when evaluating breast cancer drug sensitivity and resistance[J].Oncotarget,2016,7(29):45745-45756.doi: 10.18632/oncotarget.9935.
    [52]
    Riedl A,Schlederer M,Pudelko K,et al.Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses[J].J Cell Sci,2017,130(1):203-218.
    [53]
    Lu M,Zhou F,Hao K,et al.Alternation of adriamycin penetration kinetics in MCF-7 cells from 2D to 3D culture based on P-gp expression through the Chk2/p53/NF-κB pathway[J].Biochem Pharmacol,2015,93(2):210-220.
    [54]
    Gomez-Roman N,Stevenson K,Gilmour L,et al.A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses[J].Neuro-oncology,2017,19(2):229-241.
    [55]
    Qin Y,Roszik J,Chattopadhyay C,et al.Hypoxia-driven mechanism of vemurafenib resistance in melanoma[J].Mol Cancer Ther,2016,15(10):2442-2454.
    [56]
    Song Y, Kim JS, Choi EK, et al. TGF-β-independent CTGF induction regulates cell adhesion mediated drug resistance by increasing collagen I in HCC[J].Oncotarget,2017,8(13):21650-21662.
    [57]
    Halfter K,Hoffmann O,Ditsch N,et al.Testing chemotherapy efficacy in HER2 negative breast cancer using patient-derived spheroids[J].J Transl Med,2016,14(1):112.
    [58]
    Ando Y,Siegler EL,Ta HP,et al.Hypoxia:evaluating CAR-T cell therapy in a hypoxic 3D tumor model(adv.Healthcare mater.5/2019)[J].Adv Healthcare Mater,2019,8(5):1970015.
    [59]
    Lee SWL,Adriani G,Ceccarello E,et al.Characterizing the role of monocytes in T cell cancer immunotherapy using a 3D microfluidic model[J].Front Immunol,2018,9:416.
    • Related Articles

  • Related Articles

    [1]YAO Lei, QU Linlin, FAN Daidi. Effects of rare ginsenoside on idiopathic pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2023, 54(5): 607-613. DOI: 10.11665/j.issn.1000-5048.2023042002
    [2]QIAN Xiuhui, SUN Jing, FU San, TANG Xiaoyan, XU Xianghong, ZHANG Mian. Effect of intratracheal instillation of PM2.5 suspensionon pulmonary fibrosis in mice and the intervention of neotuberostemonine[J]. Journal of China Pharmaceutical University, 2021, 52(4): 455-462. DOI: 10.11665/j.issn.1000-5048.20210408
    [3]LI Xiaoshi, WU Xunxun, ZHENG Zuguo, YANG Hua, LI Ping. Advances of long noncoding RNAs in myocardial fibrosis[J]. Journal of China Pharmaceutical University, 2020, 51(6): 646-654. DOI: 10.11665/j.issn.1000-5048.20200602
    [4]CAI Yanfei, WAN Aini, CHEN Yun, JIN Jian. Anti-liver fibrosis activities of the extracellular domain of transforming growth factor beta type II receptor fusion protein in vivo[J]. Journal of China Pharmaceutical University, 2019, 50(2): 246-252. DOI: 10.11665/j.issn.1000-5048.20190217
    [5]XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415
    [6]FAN Qianqian, XING Lei, QIAO Jianbin, ZHANG Chenglu, JIANG Hulin. Advances in drug delivery systems for the treatment of liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(3): 263-271. DOI: 10.11665/j.issn.1000-5048.20180302
    [7]ZHAO Limeng, WANG Shuzhen. Therapeutic applications of small molecule kinase inhibitors in liver fibrosis[J]. Journal of China Pharmaceutical University, 2018, 49(2): 147-157. DOI: 10.11665/j.issn.1000-5048.20180203
    [8]XIANG Juan, YU Ping, LI Mingdan, ZHANG Chaofeng, XU Xianghong, ZHANG Mian. Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J]. Journal of China Pharmaceutical University, 2017, 48(1): 76-81. DOI: 10.11665/j.issn.1000-5048.20170112
    [9]DAI Li, ZHANG Lu, JI Hui, KONG Xiang-wen. Therapeutic effects of ZK14，a novel nitric oxide donating biphenyldicarboxylate derivative，on hepatic fibrosis in rats[J]. Journal of China Pharmaceutical University, 2009, 40(3): 254-257.
    [10]Danshen Inhibiting Isoproterenol Induced Cardiac Hypertrophy and Fibrosis in Mice and its Mechanisms[J]. Journal of China Pharmaceutical University, 2003, (6): 84-87.

Catalog

    Get Citation
    PDF
    XML
    Article views (595) PDF downloads (1170) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：308648

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return